SPAC IPO

Trajectory Alpha Acquisition’s objective is to merge with a disruptive, technology-driven business that leverages unique intellectual property and proprietary data.

Forbion will focus on life sciences companies in Europe.

The new SPAC is targeting fintech companies with an equity value of approximately $300 million to $500 million. 

Sculptor I will target the real estate sector.

The newly-formed blank check company is focused on companies in Central & Eastern Europe, Russia or the Commonwealth of Independent States.

Genesis Growth Tech will search for a target in the high growth technology and tech-enabled businesses in Europe, Israel, the United Arab Emirates and the United States.

Target Global sponsor is a European VC firm. The SPAC is broadly focused on technology companies.

The SPAC intends to focus on businesses in the health, nutrition, fitness, wellness and beauty sectors and the products, devices, applications and technology driving growth within these verticals.

The company intends to target businesses based in the United States and/or Asia (excluding China) with a focus in the technology, media and telecom (TMT), sports and entertainment, and/or non-gambling gaming sectors.

The SPAC is led by Chairman Jeb Bush and President and CEO Richard Jackson, targeting businesses with a focus on healthcare services, healthcare technology, or otherwise focused on the healthcare industry.